Literature DB >> 24846203

Retinal alterations in mild cognitive impairment and Alzheimer's disease: an optical coherence tomography study.

Francisco J Ascaso1, Nancy Cruz, Pedro J Modrego, Raul Lopez-Anton, Javier Santabárbara, Luis F Pascual, Antonio Lobo, José A Cristóbal.   

Abstract

Retinal nerve fiber layer thickness (RNFL) measured by means of Optical Coherence Tomography (OCT) has been used as a marker not only of ophthalmologic diseases but also of neurodegenerative diseases such as Alzheimer's disease (AD) and mild cognitive impairment (MCI). The purpose of this work was to demonstrate that patients with amnestic MCI show an intermediate RNFL thickness between normality and AD, and a macular volume and thickness as well. In a cross-sectional study we consecutively recruited 18 patients with AD, 21 with MCI, and 41 healthy controls. OCT was performed in all of them to measure circumpapillary RNFL thickness in µm, as well as macular volume and thickness. In the analysis of variance we saw that RNFL was thinner in MCI patients compared with controls, and it was also thinner in AD patients compared with MCI patients and controls. With regard to the macular measurements in mm(3), MCI patients had the greatest macular volume in comparison with AD patients and controls. In turn the controls had greater macular volume than AD patients. The decreased RNFL thickness in MCI and AD patients suggests loss of retinal neurons and their axons. The increased thickness and macular volume have never been reported before in aMCI. This finding could be explained by inflammation and/or gliosis in early stages of AD. OCT could be a useful marker of AD for early detection and monitoring progression.

Entities:  

Mesh:

Year:  2014        PMID: 24846203     DOI: 10.1007/s00415-014-7374-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  46 in total

Review 1.  Mild cognitive impairment: an opportunity to identify patients at high risk for progression to Alzheimer's disease.

Authors:  Allan Levey; James Lah; Felicia Goldstein; Kyle Steenland; Donald Bliwise
Journal:  Clin Ther       Date:  2006-07       Impact factor: 3.393

Review 2.  The use of optical coherence tomography in neurology.

Authors:  Cédric Lamirel; Nancy Newman; Valéerie Biousse
Journal:  Rev Neurol Dis       Date:  2009

3.  [The investigation of retinal nerve fiber loss in Alzheimer's disease].

Authors:  Ying Chi; Yin-hua Wang; Liu Yang
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2010-02

4.  Retinal thickness in patients with mild cognitive impairment and Alzheimer's disease.

Authors:  Anat Kesler; Veronika Vakhapova; Amos D Korczyn; Elvira Naftaliev; Meira Neudorfer
Journal:  Clin Neurol Neurosurg       Date:  2011-03-31       Impact factor: 1.876

Review 5.  Astrocytes in Alzheimer's disease.

Authors:  Alexei Verkhratsky; Markel Olabarria; Harun N Noristani; Chia-Yu Yeh; Jose Julio Rodriguez
Journal:  Neurotherapeutics       Date:  2010-10       Impact factor: 7.620

Review 6.  Atypical form of Alzheimer's disease with prominent posterior cortical atrophy: a review of lesion distribution and circuit disconnection in cortical visual pathways.

Authors:  P R Hof; B A Vogt; C Bouras; J H Morrison
Journal:  Vision Res       Date:  1997-12       Impact factor: 1.886

Review 7.  Neuroglia in neurodegeneration.

Authors:  Michael T Heneka; José J Rodríguez; Alexei Verkhratsky
Journal:  Brain Res Rev       Date:  2009-11-26

8.  Optic-nerve degeneration in Alzheimer's disease.

Authors:  D R Hinton; A A Sadun; J C Blanks; C A Miller
Journal:  N Engl J Med       Date:  1986-08-21       Impact factor: 91.245

9.  Visual field loss in senile dementia of the Alzheimer's type.

Authors:  G L Trick; L R Trick; P Morris; M Wolf
Journal:  Neurology       Date:  1995-01       Impact factor: 9.910

Review 10.  Biomarkers for Alzheimer's disease--clinical needs and application.

Authors:  Douglas Galasko
Journal:  J Alzheimers Dis       Date:  2005-03       Impact factor: 4.472

View more
  72 in total

1.  Exploring the role of macular thickness as a potential early biomarker of neurodegeneration in acute schizophrenia.

Authors:  Sukanto Sarkar; A R Rajalakshmi; S Avudaiappan; S Eswaran
Journal:  Int Ophthalmol       Date:  2021-04-15       Impact factor: 2.031

Review 2.  [Retinal imaging of the macula and optic disc in neurodegenerative diseases].

Authors:  G N Turski; S Schmitz-Valckenberg; F G Holz; R P Finger
Journal:  Ophthalmologe       Date:  2017-02       Impact factor: 1.059

3.  Macular Thickness in Subjective Memory Complaints and Mild Cognitive Impairment: A Non-Invasive Biomarker.

Authors:  Domingo Giménez Castejón; Miriama Dudekova; Maria Gómez Gallego; Jerónimo Lajara Blesa
Journal:  Neuroophthalmology       Date:  2016-01-19

4.  Schizophrenia and the retina: Towards a 2020 perspective.

Authors:  Steven M Silverstein; Samantha I Fradkin; Docia L Demmin
Journal:  Schizophr Res       Date:  2019-11-07       Impact factor: 4.939

5.  Folate/Vitamin B Alleviates Hyperhomocysteinemia-Induced Alzheimer-Like Pathologies in Rat Retina.

Authors:  Jing Guo; Shaozhou Ni; Qihang Li; Jian-Zhi Wang; Ying Yang
Journal:  Neurosci Bull       Date:  2018-09-28       Impact factor: 5.203

6.  Absence of Alzheimer Disease Neuropathologic Changes in Eyes of Subjects With Alzheimer Disease.

Authors:  Erik A Williams; Declan McGuone; Matthew P Frosch; Bradley T Hyman; Nora Laver; Anat Stemmer-Rachamimov
Journal:  J Neuropathol Exp Neurol       Date:  2017-05-01       Impact factor: 3.685

7.  Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis.

Authors:  Victor T T Chan; Zihan Sun; Shumin Tang; Li Jia Chen; Adrian Wong; Clement C Tham; Tien Y Wong; Christopher Chen; M Kamran Ikram; Heather E Whitson; Eleonora M Lad; Vincent C T Mok; Carol Y Cheung
Journal:  Ophthalmology       Date:  2018-08-13       Impact factor: 12.079

8.  OCT in Alzheimer's disease: thinning of the RNFL and superior hemiretina.

Authors:  João Paulo Cunha; Rita Proença; Arnaldo Dias-Santos; Rita Almeida; Helena Águas; Marta Alves; Ana Luísa Papoila; Carlota Louro; António Castanheira-Dinis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-06-22       Impact factor: 3.117

9.  Using Retinal Imaging to Study Dementia.

Authors:  Victor T T Chan; Tiffany H K Tso; Fangyao Tang; Clement Tham; Vincent Mok; Christopher Chen; Tien Y Wong; Carol Y Cheung
Journal:  J Vis Exp       Date:  2017-11-06       Impact factor: 1.355

Review 10.  Alzheimer's disease: A review of its visual system neuropathology. Optical coherence tomography-a potential role as a study tool in vivo.

Authors:  J P Cunha; N Moura-Coelho; R P Proença; A Dias-Santos; J Ferreira; C Louro; A Castanheira-Dinis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-07-04       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.